MX2017002469A - Composiciones de matrices extracelulares. - Google Patents

Composiciones de matrices extracelulares.

Info

Publication number
MX2017002469A
MX2017002469A MX2017002469A MX2017002469A MX2017002469A MX 2017002469 A MX2017002469 A MX 2017002469A MX 2017002469 A MX2017002469 A MX 2017002469A MX 2017002469 A MX2017002469 A MX 2017002469A MX 2017002469 A MX2017002469 A MX 2017002469A
Authority
MX
Mexico
Prior art keywords
ecm
extracellular matrix
compositions
elisa
measured
Prior art date
Application number
MX2017002469A
Other languages
English (en)
Inventor
Herzberg Uri
Ye Qian
Kaplunovsky Aleksandr
B Bhatia Mohit
ZAKA Raihana
Original Assignee
Hli Cellular Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hli Cellular Therapeutics Llc filed Critical Hli Cellular Therapeutics Llc
Publication of MX2017002469A publication Critical patent/MX2017002469A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Abstract

Se proporcionan aquí composiciones de matriz extracelular placentaria (CME) y métodos para fabricarlas. También se proporcionan usos de las composiciones placentarias CME proporcionadas en la presente memoria.
MX2017002469A 2014-08-25 2015-08-25 Composiciones de matrices extracelulares. MX2017002469A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462041468P 2014-08-25 2014-08-25
PCT/US2015/046690 WO2016033041A1 (en) 2014-08-25 2015-08-25 Extracellular matrix compositions

Publications (1)

Publication Number Publication Date
MX2017002469A true MX2017002469A (es) 2017-05-19

Family

ID=55400430

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017002469A MX2017002469A (es) 2014-08-25 2015-08-25 Composiciones de matrices extracelulares.

Country Status (16)

Country Link
US (1) US20170056479A1 (es)
EP (1) EP3185888B1 (es)
JP (3) JP2017525732A (es)
KR (2) KR20170040809A (es)
CN (1) CN106794227B (es)
AU (2) AU2015306811A1 (es)
BR (1) BR112017003905A2 (es)
CA (1) CA2958211C (es)
EA (1) EA201790461A1 (es)
IL (1) IL250753A0 (es)
MX (1) MX2017002469A (es)
MY (1) MY193650A (es)
NZ (1) NZ729021A (es)
SG (2) SG10201901713RA (es)
WO (1) WO2016033041A1 (es)
ZA (1) ZA201701059B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3074089A4 (en) 2013-11-26 2017-07-26 Alliqua Biomedical, Inc. Systems and methods for producing and delivering ultrasonic therapies for wound treatment and healing
JP6712160B2 (ja) * 2016-03-29 2020-06-17 株式会社Adeka エンドトキシン測定のための前処理方法及びその測定方法
CA3029233A1 (en) 2016-06-24 2017-12-28 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
AU2017302612A1 (en) * 2016-07-29 2019-03-14 Alliqua Biomedical, Inc. Systems and methods for delivering cellular and biological materials using ultrasound for wound treatment and healing
CN107349463A (zh) * 2017-06-16 2017-11-17 卓阮医疗科技（苏州）有限公司 一种生物源性止血微粒及其制备方法
US11026980B1 (en) * 2018-02-26 2021-06-08 Triad Life Sciences, Inc. Flowable birth tissue composition and related methods
CN109125799A (zh) * 2018-09-05 2019-01-04 张强 GelMA水凝胶人脱细胞羊膜三维双层辅料的制备方法
CN110841115A (zh) * 2019-11-13 2020-02-28 中国科学院遗传与发育生物学研究所 一种胶原凝胶支架及其在提高自体脂肪细胞移植存活率中的应用
EP4157375A1 (en) * 2020-05-26 2023-04-05 Convatec Triad Life Sciences, LLC. Modified porcine scaffolds and methods of preparation
JP7189468B2 (ja) 2021-01-08 2022-12-14 ダイキン工業株式会社 不具合箇所推定システム、不具合箇所推定方法、及びプログラム

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615373B2 (en) * 1999-02-25 2009-11-10 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
CN1478547A (zh) * 2002-08-28 2004-03-03 赵晓红 胶原蛋白保健胶囊
JP5425399B2 (ja) * 2004-12-23 2014-02-26 エシコン・インコーポレイテッド 産褥由来細胞を用いたパーキンソン病および関連の障害の治療
US8491457B2 (en) * 2005-03-11 2013-07-23 Wake Forest University Health Services Tissue engineered blood vessels
AT502395B1 (de) * 2005-07-27 2007-03-15 Iep Gmbh Oxidoreduktasen zur stereoselektiven reduktion von ketoverbindungen
CN1739797A (zh) * 2005-09-06 2006-03-01 易康富生物科技(南通)有限公司 一种补充胶原蛋白的复合配方
CN101589139B (zh) * 2005-10-31 2014-04-16 株式会社现代组织工学 包含获得自肋软骨的软骨细胞的人工软骨及其制备方法
CN104623643A (zh) * 2006-10-06 2015-05-20 人类起源公司 天然(端肽)胎盘胶原组合物
US20080279833A1 (en) * 2007-05-10 2008-11-13 Matheny Robert G Laminate sheet articles for tissue regeneration
US20090023885A1 (en) * 2007-07-16 2009-01-22 Texas State University - San Marcos Treatment method for imparting high impact resistance in certain cbdo copolymers
CA2694700C (en) * 2007-07-27 2015-04-14 Humacyte, Inc. Compositions and methods for soft tissue augmentation
WO2010053918A1 (en) * 2008-11-05 2010-05-14 Hancock Jaffe Laboratories, Inc. Composite containing collagen and elastin as a dermal expander and tissue filler
EP2432495B1 (en) * 2009-05-20 2017-03-22 Humacyte, Inc. Elastin for soft tissue augmentation
US8652500B2 (en) * 2009-07-22 2014-02-18 Acell, Inc. Particulate tissue graft with components of differing density and methods of making and using the same
WO2011031489A2 (en) * 2009-08-25 2011-03-17 Tissuetech, Inc. Umbilical cord amniotic membrane products
US9908691B2 (en) * 2010-06-30 2018-03-06 Gpcp Ip Holdings Llc Dispenser and sheet product dispensing plate therefor
US8722854B2 (en) * 2010-12-23 2014-05-13 Medskin Solutions Dr. Suwelack Ag Degradation-stabilised, biocompatible collagen matrices
US20120189586A1 (en) * 2011-01-21 2012-07-26 Carl Randall Harrell Human Placental Derived Extracellular Matrix and Uses Therof
CN107760646A (zh) * 2012-09-04 2018-03-06 人类起源公司 组织产生方法
JP2016501245A (ja) * 2012-12-07 2016-01-18 アントフロゲネシス コーポレーション 胎盤細胞外マトリクスを使用する口腔病変の治療
EP3027235A1 (en) * 2013-07-30 2016-06-08 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
WO2015123183A1 (en) * 2014-02-11 2015-08-20 Anthrogenesis Corporation Micro-organoids, and methods of making and using the same

Also Published As

Publication number Publication date
EP3185888B1 (en) 2023-06-07
EA201790461A1 (ru) 2017-07-31
CN106794227A (zh) 2017-05-31
AU2015306811A1 (en) 2017-03-09
ZA201701059B (en) 2018-04-25
SG11201701114UA (en) 2017-03-30
BR112017003905A2 (pt) 2018-03-06
NZ729021A (en) 2022-12-23
JP2022130466A (ja) 2022-09-06
IL250753A0 (en) 2017-04-30
MY193650A (en) 2022-10-21
KR20230129618A (ko) 2023-09-08
WO2016033041A1 (en) 2016-03-03
CA2958211A1 (en) 2016-03-03
EP3185888A4 (en) 2018-06-20
US20170056479A1 (en) 2017-03-02
AU2021202201A1 (en) 2021-05-06
JP2020142114A (ja) 2020-09-10
CA2958211C (en) 2023-09-26
CN106794227B (zh) 2022-03-01
JP2017525732A (ja) 2017-09-07
KR20170040809A (ko) 2017-04-13
EP3185888A1 (en) 2017-07-05
SG10201901713RA (en) 2019-03-28

Similar Documents

Publication Publication Date Title
MX2017002469A (es) Composiciones de matrices extracelulares.
MX359475B (es) Composiciones antitranspirantes y desodorantes.
MX2016004556A (es) Composicion de hueso comprimido y metodo para usar la misma.
MX2017012206A (es) Proliferacion ex vivo de celulas epiteliales.
CU20140141A7 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas
IN2015DN02634A (es)
WO2015048344A3 (en) Silk/platelet composition and use thereof
MX2012015203A (es) Composiciones transparentes de limpieza de baja irritacion con ph relativamente bajo.
MX2013004061A (es) Analogos de ciclosporina.
MX2017014245A (es) Composiciones que comprenden celulas germinales mesenquimales y usos de las mismas.
PH12017501070A1 (en) Peptides and their use in the treatment of skin
SG10201806020VA (en) Electroactive bioadhesive compositions
MY161601A (en) Films and compositions comprising the same
GEP201706760B (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
MX2013004062A (es) Analogos de ciclosporina.
MX367393B (es) Composiciones antifungicas para el tratamiento de piel y uñas.
AU2013408771A8 (en) Prebiotic oral care compositions containing an alkyl glycoside
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
BR112015013125A2 (pt) tratamento de lesões orais usando composições de matrix placentário extracelular
MX2015006986A (es) Solucion de trombina y metodos de uso de esta.
MX2015016410A (es) Esteres de acidos oligo-hidroxicarboxilicos y uso de los mismos.
NZ710949A (en) Modified glycolipids and methods of making and using the same
MX2018007468A (es) Composiciones de colageno 7 y metodos para usar las mismas.
MX2012007599A (es) Composiciones para formar peliculas que tienen un grado deseado de cobertura y metodos para hacer y usar las mismas.
MX2016016229A (es) Producto cosmetico con factores de crecimiento liposomados.